Skip to main content

Advertisement

SpringerLink
Log in

Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions

  • Published:
The AAPS Journal Aims and scope Submit manuscript

Abstract

Drug-induced hypersensitivity reactions are instructive examples of immune reactions against low molecular weight compounds. Classically, such reactions have been explained by the hapten concept, according to which the small antigen covalently modifies an endogenous protein; recent studies show strong associations of several HLA molecules with hypersensitivity. In recent years, however, evidence has become stronger that not all drugs need to bind covalently to the major histocompatibility complex (MHC)-peptide complex in order to trigger an immune response. Rather, some drugs may bind reversibly to the MHC or possibly to the T-cell receptor (TCR), eliciting immune reactions akin to the pharmacological activation of other receptors. While the exact mechanism is still a matter of debate, noncovalent drug presentation clearly leads to the activation of drug-specific T cells. In some patients with hypersensitivity, such a response may occur within hours of even the first exposure to the drug. Thus, the reaction to the drug may not be the result of a classical, primary response but rather be mediated by existing, preactivated T cells that display cross-reactivity for the drug and have additional (peptide) specificity as well. In this way, certain drugs may circumvent the checkpoints for immune activation imposed by the classical antigen processing and presentation mechanisms, which may help to explain the idiosyncratic nature of many drug hypersensitivity reactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Park BK, Pirmohamed M, Kitteringham NR. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective.Chem Res Toxicol. 1998;11:969–987.

    Article  CAS  PubMed  Google Scholar 

  2. Naisbitt DJ, Gordon SF, Pirmohamed M, Park BK. Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment.Drug Saf. 2000;23:483–507.

    Article  CAS  PubMed  Google Scholar 

  3. Pichler WJ. Delayed drug hypersensitivity reactions.Ann Intern Med. 2003;139:683–693.

    Article  CAS  PubMed  Google Scholar 

  4. Manfredi M, Severino M, Testi S, et al. Detection of specific IgE to quinolones.J Allergy Clin Immunol. 2004;113:155–160.

    Article  CAS  PubMed  Google Scholar 

  5. Pichler WJ, Schnyder B, Zanni MP, Hari Y, von Greyerz S. Role of T cells in drug allergies.Allergy. 1998;53:225–232.

    Article  CAS  PubMed  Google Scholar 

  6. Yawalkar N, Egli F, Hari Y, Nievergelt H, Braathen LR, Pichler WJ. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions.Clin Exp Allergy. 2000;30:847–855.

    Article  CAS  PubMed  Google Scholar 

  7. Naisbitt DJ, Farrell J, Wong G, et al. Characterization of drug-specific T cells in lamotrigine hypersensitivity.J Allergy Clin Immunol. 2003;111:1393–1403.

    Article  CAS  PubMed  Google Scholar 

  8. Naisbitt DJ, Britschgi M, Wong G, et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones.Mol Pharmacol. 2003;63:732–741.

    Article  CAS  PubMed  Google Scholar 

  9. Pichler WJ. Drug-induced autoimmunity.Curr Opin Allergy Clin Immunol. 2003;3:249–253.

    Article  CAS  PubMed  Google Scholar 

  10. Padovan E, Bauer T, Tongio MM, Kalbacher H, Weltzien HU. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy.Eur J Immunol. 1997;27:1303–1307.

    Article  CAS  PubMed  Google Scholar 

  11. Cavani A, Hackett CJ, Wilson KJ, Rothbard JB, Katz SI. Characterization of epitopes recognized by hapten-specific CD4+T cells.J Immunol. 1995;154:1232–1238.

    CAS  PubMed  Google Scholar 

  12. Cavani A, Mei D, Guerra E, et al. Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses: evidence for the presence of effector CD8+ and regulatory CD4+T cells.J Invest Dermatol. 1998;111:621–628.

    Article  CAS  PubMed  Google Scholar 

  13. Gamerdinger K, Moulon C, Karp DR, et al. A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel.J Exp Med. 2003;197:1345–1353.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lu L, Vollmer J, Moulon C, Weltzien HU, Marrack P, Kappler J. Components of the ligand for a Ni++ reactive human T cell clone.J Exp Med. 2003;197:567–574.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Griem P, Wulferink M, Sachs B, Gonzalez JB, Gleichmann E. Allergic and autoimmune reactions to xenobiotics: how do they arise?Immunol Today. 1998;19:133–141.

    Article  CAS  PubMed  Google Scholar 

  16. Knowles SR, Uetrecht J, Shear NH. Idiosyncratic drug reactions: the reactive metabolite syndromes.Lancet. 2000;356:1587–1591.

    Article  CAS  PubMed  Google Scholar 

  17. Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones.J Clin Invest. 1997;100:136–141.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Zanni MP, von Greyerz S, Schnyder B, et al. HLA-restricted, processing-and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes.J Clin Invest. 1998;102:1591–1598.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Zanni MP, von Greyerz S, Hari Y, Schnyder B, Pichler, WJ. Recognition of local anesthetics by alphabeta+T cell.J Invest Dermatol. 1999;112:197–204.

    Article  CAS  PubMed  Google Scholar 

  20. Zanni MP, Mauri-Hellweg D, Brander C, et al. Characterization of lidocaine-specific T cells.J Immunol. 1997;158:1139–1148.

    CAS  PubMed  Google Scholar 

  21. Sieben S, Kawakubo Y, Al Masaoudi T, Merk HF, Blomeke B. Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones.J Allergy Clin Immunol. 2002;109:1005–1011.

    Article  CAS  PubMed  Google Scholar 

  22. Depta JP, Altznauer F, Gamerdinger K, Burkhart C, Weltzien HU, Pichler WJ. Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity.J Allergy Clin Immunol. 2004;113:519–527.

    Article  CAS  PubMed  Google Scholar 

  23. Cribb AE, Spielberg SP. Sulfam ethoxazole is metabolized to the hydroxylamine in humans.Clin Pharmacol Ther. 1992;51:522–526.

    Article  CAS  PubMed  Google Scholar 

  24. Naisbitt DJ, Vilar FJ, Stalford AC, Wilkins EG, Pirmohamed M, Park BK. Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection.AIDS Res Hum Retroviruses. 2000;16:1929–1938.

    Article  CAS  PubMed  Google Scholar 

  25. Schnyder B, Burkhart C, Schnyder-Frutig K, et al. Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+T cells from allergic individuals.J Immunol. 2000; 164:6647–6654.

    Article  CAS  PubMed  Google Scholar 

  26. Burkhart C, von Greyerz S, Depta JP, et al. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+T cells.Br J Pharmacol. 2001;132:623–630.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Zanni MP, von Greyerz S, Schnyder B, Wendland T, Pichler WJ. Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific alphabeta+T-cell clones.Int Immunol. 1998;10:507–515.

    Article  CAS  PubMed  Google Scholar 

  28. von Greyerz S, Bultemann G, Schnyder K, et al. Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones.Int Immunol. 2001;13:877–885.

    Article  Google Scholar 

  29. Burkhart C, Britschgi M, Strasser I, et al. Non-covalent presentation of sulfamethoxazole to human CD4+T cells is independent of distinct human leucocyte antigen-bound peptides.Clin Exp Allergy. 2002;32:1635–1643.

    Article  CAS  PubMed  Google Scholar 

  30. Pirmohamed M, Park BK, Cytochrome P450 enzyme polymorphisms and adverse drug reactions.Toxicology. 2003;192:23–32.

    Article  CAS  PubMed  Google Scholar 

  31. Alfirevic A, Stalford AC, Vilar FJ, Wilkins EG, Park BK, Pirmohamed M. Slow acetylator phenotype and genotype in HIV-positive patients with sulphamethoxazole hypersensitivity.Br J Clin Pharmacol. 2003;55:158–165.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Pirmohamed M, Lin K, Chadwick D, Park BK. TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients.Neurology. 2001;56:890–896.

    Article  CAS  PubMed  Google Scholar 

  33. Mallal S, Nolan D, Witt C, et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor acacavir.Lancet. 2002;359:727–732.

    Article  CAS  PubMed  Google Scholar 

  34. Martin AM, Nolan D, Gaudieri S, et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.Proc Natl Acad Sci USA. 2004;101:4180–4185.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson syndrome.Nature. 2004;428:486.

    Article  CAS  PubMed  Google Scholar 

  36. Hung SI, Chung WH, Liou LB, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.Proc Natl Acad Sci USA. 2005;102:4134–4139.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Christiansen C, Pichler WJ, Skotland T. Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations.Eur Radiol. 2000;10:1965–1975.

    Article  CAS  PubMed  Google Scholar 

  38. Christiansen C. Late-onset allergy-like reactions to X-ray contrast media.Curr Opin Allergy Clin Immunol. 2002;2:333–339.

    Article  PubMed  Google Scholar 

  39. Pirmohamed M, Park BK. Genetic susceptibility to adverse drug reactions.Trends Pharmacol Sci. 2001;22:298–305.

    Article  CAS  PubMed  Google Scholar 

  40. Vollmer J, Weltzien HU, Dormoy A, Pistoor F, Moulon C. Functional expression and analysis of a human HLA-DQ restricted, nickel-reactive T-cell receptor in mouse hybridoma cells.J Invest Dermatol. 1999;113:175–181.

    Article  CAS  PubMed  Google Scholar 

  41. Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept.Curr Opin Allergy Clin Immunol. 2002;2:301–305.

    Article  PubMed  Google Scholar 

  42. Thierse HJ, Gamerdinger K, Junkes C, Guerreiro N, Weltzien HU. T-cell receptor (TCR) interaction with haptens: metal ions as non-classical haptens.Toxicology. 2005;209:101–107.

    Article  CAS  PubMed  Google Scholar 

  43. Stockl J, Majdic O, Fischer G, Maurer D, Knapp W. Monomorphic molecules function as additional recognition structures on haptenated target cells for HLA-A1-restricted, hapten-specific CTL.J Immunol. 2001;167:2724–2733.

    Article  CAS  PubMed  Google Scholar 

  44. Beeley NR. Can peptides be mimicked?.Drug Discov Today. 2000;5:354–363.

    Article  CAS  PubMed  Google Scholar 

  45. Mason D. A very high level of cross-reactivity is an essential feature of the T-cell receptor.Immunol Today. 1998;19:395–404.

    Article  CAS  PubMed  Google Scholar 

  46. Pirmohamed M, Park BK. HIV and drug allergy.Curr Opin Allergy Clin Immunol. 2001;1:311–316.

    Article  CAS  PubMed  Google Scholar 

  47. Engler OB, Strasser I, Naisbitt DJ, Cerny A, Pichler WJ. A chemically inert drug can stimulate T cells in vitro by their T-cell receptor in non-sensitized individuals.Toxicology. 2004;197:47–56.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Allergology, Clinic for Rheumatology and Clinical Immunology/Allergology, PKT2 D572; Inselspital, CH-3010, Berne, Switzerland

    Basil O. Gerber & Werner J. Pichler

Authors
  1. Basil O. Gerber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Werner J. Pichler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Werner J. Pichler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gerber, B.O., Pichler, W.J. Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions. AAPS J 8, 19 (2006). https://doi.org/10.1208/aapsj080119

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/aapsj080119

Keywords

Search

Navigation